Stay updated on Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Major update: adds a government-status notice and the new software version v3.2.0, replaces the old v3.0.2.
    Difference
    3%
    Check dated 2025-10-02T01:28:49.000Z thumbnail image
  4. Check
    17 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-30T14:19:06.000Z thumbnail image
  5. Check
    24 days ago
    Change Detected
    Summary
    The page shift moves from biology/protein content to economics and health care economics/taxes, removing protein-related topics and adding new economic and healthcare economics sections. This represents a substantial change in core topics.
    Difference
    0.6%
    Check dated 2025-09-23T10:58:44.000Z thumbnail image
  6. Check
    32 days ago
    Change Detected
    Summary
    Updated from v3.0.1 to v3.0.2; removed the 'Back to Top' element. No other substantive changes detected.
    Difference
    0.2%
    Check dated 2025-09-16T05:33:21.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.2%
    Check dated 2025-09-09T01:13:22.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new medical topics related to bladder cancer and urologic diseases. Notably, the version has been updated from v2.16.12 to v3.0.0.
    Difference
    4%
    Check dated 2025-09-01T21:08:57.000Z thumbnail image

Stay in the know with updates to Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.